Septin9 DNA methylation as a promising biomarker for cervical cancer

Bu, QW; Luo, XP; He, LL; Ma, J; He, SY; Lei, W; Zhou, WP; Deng, H; Lin, Y; Zhang, L; Hong, XS

Lin, Y (通讯作者)，Southern Med Univ, Nanfang Hosp, 1838 North Guangzhou Ave, Guangzhou 511400, Guangdong, Peoples R China.;Lin, Y (通讯作者)，Guangzhou Univ Chinese Med, 12 Airport Rd, Guangzhou, Peoples R China.;Zhang, L (通讯作者)，Guangdong Women & Children Hosp, Translat Med Ctr, 521 Xing Nan Rd, Guangzhou 511400, Guangdong, Peoples R China.;Hong, XS (通讯作者)，Guangdong Women & Children Hosp, Dept Gynecol, 521 Xing Nan Rd, Guangzhou 511400, Guangdong, Peoples R China.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023; 43 (1):

Abstract

Aberrant Septin9 methylation in cervical cancer has been rarely studied. We aimed to identify its diagnostic value in cervical cancer using cervical s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索